Aubagio is a medicine that contains the active substance teriflunomide. It is used to treat patients from the age of 10 years with multiple sclerosis (MS), a disease in which inflammation destroys the protective sheath around the nerves. Aubagio is used in the type of MS known as relapsing-remitting MS, when the patient has flare-ups of symptoms (relapses) followed by periods of recovery (remissions).
Therapeutic Indication
### Therapeutic indication AUBAGIO is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (MS) (please refer to section 5.1 for important information on the population for which efficacy has been established).
Therapeutic Area (MeSH)
ATC Code
L04AK02
ATC Item
teriflunomide
Pharmacotherapeutic Group
Selective immunosuppressants
Active Substance (Summary)
INN / Common Names
EMA Name
Aubagio
Medicine Name
Aubagio
Aliases
N/ANo risk management plan link.
